<VariationArchive VariationID="2014354" VariationName="NM_001453.3(FOXC1):c.973_976dup (p.Ala326fs)" VariationType="Duplication" Accession="VCV002014354" Version="2" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-02-20" DateCreated="2023-02-08" MostRecentSubmission="2024-02-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="2074850" VariationID="2014354">
      <GeneList>
        <Gene Symbol="FOXC1" FullName="forkhead box C1" GeneID="2296" HGNC_ID="HGNC:3800" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>6p25.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="6" Accession="NC_000006.12" start="1609915" stop="1613897" display_start="1609915" display_stop="1613897" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="6" Accession="NC_000006.11" start="1610680" stop="1614131" display_start="1610680" display_stop="1614131" Strand="+" />
          </Location>
          <OMIM>601090</OMIM>
          <Haploinsufficiency last_evaluated="2020-07-29" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=FOXC1">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-07-29" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=FOXC1">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_001453.3(FOXC1):c.973_976dup (p.Ala326fs)</Name>
      <CanonicalSPDI>NC_000006.12:1611415:CGGCCG:CGGCCGGCCG</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>6p25.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="6" Accession="NC_000006.12" start="1611415" stop="1611416" display_start="1611415" display_stop="1611416" variantLength="4" positionVCF="1611415" referenceAlleleVCF="G" alternateAlleleVCF="GCGGC" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="6" Accession="NC_000006.11" start="1611650" stop="1611651" display_start="1611650" display_stop="1611651" variantLength="4" positionVCF="1611650" referenceAlleleVCF="G" alternateAlleleVCF="GCGGC" />
      </Location>
      <ProteinChange>A326fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000006.11" sequenceAccession="NC_000006" sequenceVersion="11" change="g.1611653_1611656dup" Assembly="GRCh37">
            <Expression>NC_000006.11:g.1611653_1611656dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000006.12" sequenceAccession="NC_000006" sequenceVersion="12" change="g.1611418_1611421dup" Assembly="GRCh38">
            <Expression>NC_000006.12:g.1611418_1611421dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009368.1" sequenceAccession="NG_009368" sequenceVersion="1" change="g.5973_5976dup">
            <Expression>NG_009368.1:g.5973_5976dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001453.3" sequenceAccession="NM_001453" sequenceVersion="3" change="c.973_976dup" MANESelect="true">
            <Expression>NM_001453.3:c.973_976dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001444.2" sequenceAccession="NP_001444" sequenceVersion="2" change="p.Ala326fs">
            <Expression>NP_001444.2:p.Ala326fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_1245" sequenceAccession="LRG_1245">
            <Expression>LRG_1245:g.5973_5976dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_1245t1" sequenceAccession="LRG_1245t1">
            <Expression>LRG_1245t1:c.973_976dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_1245p1" sequenceAccession="LRG_1245p1" change="p.Ala326fs">
            <Expression>LRG_1245p1:p.Ala326fs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001453.3(FOXC1):c.973_976dup (p.Ala326fs) AND Axenfeld-Rieger syndrome type 3" Accession="RCV002861448" Version="2">
        <ClassifiedConditionList TraitSetID="2331">
          <ClassifiedCondition DB="MedGen" ID="C2678503">Axenfeld-Rieger syndrome type 3</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-08-03" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-08-03" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2023-02-08" MostRecentSubmission="2024-02-20">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">11170889</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">16936096</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">20881294</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="2331" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="371" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">AXENFELD-RIEGER ANOMALY WITH CARDIAC DEFECTS AND/OR SENSORINEURAL HEARING LOSS</ElementValue>
                <XRef Type="MIM" ID="602482" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Axenfeld-Rieger syndrome type 3</ElementValue>
                <XRef ID="Axenfeld+Rieger+Syndrome+Type+3/694" DB="Genetic Alliance" />
                <XRef ID="MONDO:0011233" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Axenfeld-rieger anomaly with or without cardiac defects and/or sensorineural hearing loss</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Rieger syndrome type 3</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Anterior chamber cleavage syndrome</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">RIEG3</ElementValue>
                <XRef Type="MIM" ID="602482" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="9626" />
                <XRef ID="9626" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGentest, 2011">
                <ID Source="pmc">3061995</ID>
              </Citation>
              <XRef ID="782" DB="Orphanet" />
              <XRef ID="C2678503" DB="MedGen" />
              <XRef ID="MONDO:0011233" DB="MONDO" />
              <XRef Type="MIM" ID="602482" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="5901979" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2023-02-07">
        <ClinVarSubmissionID localKey="17037647|MedGen:C2678503" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003214688" DateUpdated="2024-02-20" DateCreated="2023-02-07" Type="SCV" Version="2" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-08-03">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">11170889</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16936096</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20881294</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Ala326Glyfs*203) in the FOXC1 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 228 amino acid(s) of the FOXC1 protein. This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with FOXC1-related conditions. This variant disrupts a region of the FOXC1 protein in which other variant(s) (p.Ala381Glyfs*147) have been determined to be pathogenic (PMID: 11170889, 16936096, 20881294). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FOXC1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000006.11:g.1611650_1611651insCGGC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C2678503" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12507860</SubmissionName>
          <SubmissionName>SUB14200279</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="5901979" TraitType="Disease" MappingType="XRef" MappingValue="C2678503" MappingRef="MedGen">
        <MedGen CUI="C2678503" Name="Axenfeld-Rieger syndrome type 3" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

